{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:15:43Z","timestamp":1749701743268,"version":"3.41.0"},"reference-count":4,"publisher":"Massachusetts Medical Society","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2022,10,6]]},"DOI":"10.1056\/nejmc2210918","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T21:06:57Z","timestamp":1665004017000},"page":"1336-1337","source":"Crossref","is-referenced-by-count":2,"title":["Phase 1\u20132 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B"],"prefix":"10.1056","volume":"387","member":"150","reference":[{"key":"e_1_2_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2119913"},{"key":"e_1_2_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00670"},{"key":"e_1_2_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004625"},{"key":"e_1_2_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1055\/a-1282-2286"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMc2210918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:09:16Z","timestamp":1749683356000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMc2210918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,6]]},"references-count":4,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2022,10,6]]}},"alternative-id":["10.1056\/NEJMc2210918"],"URL":"https:\/\/doi.org\/10.1056\/nejmc2210918","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"type":"print","value":"0028-4793"},{"type":"electronic","value":"1533-4406"}],"subject":[],"published":{"date-parts":[[2022,10,6]]}}}